Identify the role of biomarkers in the diagnosis of pediatric and adult CNS and PNS tumors.
Identify standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
Recognize and address neurological complications associated with new cancer therapies.
Identify and manage long-term complications of CNS and PNS tumors and their treatment.
Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day CME course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer.
This accredited course is offered by Mass General Brigham, Dana-Farber Institute and Boston Children's Hospital. This course is targeted toSpecialty Physicians, Nurses, Pharmacists, Physician Assistants and Psychologists.
Contact ceprograms@hms.harvard.edu with questions.
